What question did this study set out to answer?

To review recent advances in the epidemiology, pathogenesis, clinical presentation, diagnosis, and treatment of renal involvement in Fabry disease.

August 16, 2026Renal FailureOpen Access

Clinical manifestations, diagnosis, and management of renal involvement in Fabry disease

View Full Paper

Ask AI

Bookmark

Authors

WGWenkai Guo JBJingru Bi PJPengcheng Ji

Discussion

Member takes

Overview

Narrative review outlines diagnostic and management strategies for renal involvement in Fabry disease, highlighting the critical role of early intervention to prevent organ damage.

Key Points

To review recent advances in the epidemiology, pathogenesis, clinical presentation, diagnosis, and treatment of renal involvement in Fabry disease.
Synthesized current literature detailing the clinical progression and molecular mechanisms of Fabry disease.
Assessed diagnostic markers, differential diagnoses, and therapeutic strategies focused on preserving renal and systemic organ function.
Reduced or absent α-galactosidase A enzyme activity leads to progressive substrate accumulation across organs, with renal disease acting as a primary driver of morbidity.
Early identification and therapeutic intervention slow renal function decline and may significantly lower the risk of subsequent cardiovascular and cerebrovascular events.

Cite This Study

Guo et al. (2026) studied this question.

synapsesocial.com/papers/6a8179abf2fb91fc834acf56 https://doi.org/10.1080/0886022x.2026.2702129

View Full Paper

Ask AI

Bookmark

August 16, 2026Renal FailureOpen Access

Clinical manifestations, diagnosis, and management of renal involvement in Fabry disease

View Full Paper

Ask AI

Bookmark

Authors

WGWenkai Guo JBJingru Bi PJPengcheng Ji

Discussion

Member takes

Overview

Narrative review outlines diagnostic and management strategies for renal involvement in Fabry disease, highlighting the critical role of early intervention to prevent organ damage.

Key Points

To review recent advances in the epidemiology, pathogenesis, clinical presentation, diagnosis, and treatment of renal involvement in Fabry disease.
Synthesized current literature detailing the clinical progression and molecular mechanisms of Fabry disease.
Assessed diagnostic markers, differential diagnoses, and therapeutic strategies focused on preserving renal and systemic organ function.
Reduced or absent α-galactosidase A enzyme activity leads to progressive substrate accumulation across organs, with renal disease acting as a primary driver of morbidity.
Early identification and therapeutic intervention slow renal function decline and may significantly lower the risk of subsequent cardiovascular and cerebrovascular events.

Cite This Study

Guo et al. (2026) studied this question.

synapsesocial.com/papers/6a8179abf2fb91fc834acf56 https://doi.org/10.1080/0886022x.2026.2702129

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

View Full Paper

Ask AI

Bookmark